InvestorsHub Logo
Followers 80
Posts 24703
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 10/17/2019 8:16:45 AM

Thursday, October 17, 2019 8:16:45 AM

Post# of 27622
FOMX - 3.09 Pre-market now at 3.20/3.30

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

https://www.tradescores.com/StockReport/fomx
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.